Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2010, Article ID 161454, 5 pages
http://dx.doi.org/10.1155/2010/161454
Case Report

Piperacillin-Induced Immune Hemolytic Anemia in an Adult with Cystic Fibrosis

1Department of Medicine, University of Vermont and Maine Medical Center, 22 Bramhall St., Portland, ME 04102, USA
2American Red Cross Blood Services, Southern California Region, Pomona, CA 91768, USA

Received 14 September 2009; Accepted 1 April 2010

Academic Editor: Moshe Mittelman

Copyright © 2010 Mahesh Bandara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. H. Goss and J. L. Burns, “Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis,” Thorax, vol. 62, no. 4, pp. 360–367, 2007. View at Publisher · View at Google Scholar · View at PubMed
  2. C. Johnson, S. M. Butler, M. W. Konstan, W. Morgan, and M. E. B. Wohl, “Factors influencing outcomes in cystic fibrosis: a center-based analysis,” Chest, vol. 123, no. 1, pp. 20–27, 2003. View at Publisher · View at Google Scholar
  3. D. B. Seder and J. B. Zuckerman, “Piperacillin-indued immune hemolytic anemia in a woman with cystic fibrosis,” Chest, vol. 130, no. 4, p. 325S, 2006. View at Google Scholar
  4. P. A. Arndt, G. Garratty, J. Hill, M. Kasper, and V. Chandrasekaran, “Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the ‘immune complex’ method,” Vox Sanguinis, vol. 83, no. 3, pp. 273–278, 2002. View at Publisher · View at Google Scholar
  5. R. M. Leger, P. A. Arndt, and G. Garratty, “Serological studies of piperacillin antibodies,” Transfusion, vol. 48, no. 11, pp. 2429–2434, 2008. View at Publisher · View at Google Scholar · View at PubMed
  6. C. A. Naranjo, U. Busto, E. M. Sellers et al., “A method for estimating the probability of adverse drug reactions,” Clinical Pharmacology and Therapeutics, vol. 30, no. 2, pp. 239–245, 1981. View at Google Scholar
  7. K. M. Thickett, M. J. Wildman, C. D. Fegan, and D. E. Stableforth, “Haemolytic anaemia following treatment with piperacillin in a patient with cystic fibrosis,” Journal of Antimicrobial Chemotherapy, vol. 43, no. 3, pp. 435–436, 1999. View at Google Scholar
  8. S. T. Johnson, L. A. Weitekamp, D. E. Sauer, J. T. Fueger, and R. H. Aster, “Piperacillin-dependent antibody with relative e specificity reacting with drug treated red cells and untreated red cells in the presence of drug,” Transfusion, vol. 34, p. 70S, 1994. View at Google Scholar
  9. Y. M. Audeh and G. Wehrli, “Hemolytic anemia due to Zosyn and the blood bank physician's role,” Transfusion, vol. 42, supplement 1, p. 106S, 2002, abstract. View at Google Scholar
  10. R. Shirey, J. Iding, and K. E. King, “Drug-induced immune hemolysis mimicking an acute hemolytic transfusion reaction,” Transfusion, vol. 45, p. 100A, 2005. View at Google Scholar
  11. I. Mohammed and K. Greer, “Severe acute hemolytic anemia due to piperacillin,” Critical Care Medicine, vol. 33, no. 12, p. A182, 2005, case report. View at Google Scholar
  12. R. S. Shirey, C. Yamada, P. M. Ness, and K. E. King, “Drug-induced immune hemolytic anemia imitating a severe delayed hemolytic transfusion reaction,” Transfusion, vol. 47, p. 185A, 2007. View at Google Scholar
  13. J. M. Garcia Gala, S. Vazquez Aller, P. Rodriguez Vicente, and C. Morante Pombo, “Immune hemolysis due to piperacillin/tazobactam,” Transfusion and Apheresis Science, vol. 40, no. 2, pp. 97–98, 2009. View at Publisher · View at Google Scholar · View at PubMed
  14. P. A. Arndt and G. Garratty, “The changing spectrum of drug-induced immune hemolytic anemia,” Seminars in Hematology, vol. 42, no. 3, pp. 137–144, 2005. View at Publisher · View at Google Scholar
  15. S. T. Johnson, J. T. Fueger, and J. L. Gottschall, “One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia—a new paradigm,” Transfusion, vol. 47, no. 4, pp. 697–702, 2007. View at Publisher · View at Google Scholar · View at PubMed
  16. G. Garratty and P. A. Arndt, “An update on drug-induced immune hemolytic anemia,” Immunohematology, vol. 23, no. 3, pp. 105–119, 2007. View at Google Scholar
  17. R. R. Engel, F. L. Rodkey, and C. E. Krill Jr., “Carboxyhemoglobin levels as an index of hemolysis,” Pediatrics, vol. 47, no. 4, pp. 723–730, 1971. View at Google Scholar
  18. S. T. Johnson, J. T. Fueger, D. E. Sauer, and J. A. Bell, “Drug-induced immune hemolytic anemia associated with Zosyn, serologically presenting as warm autoimmune hemolytic anemia and detected best in the presence of Zosyn,” Transfusion, vol. 46, pp. 127A–128A, 2006. View at Google Scholar
  19. S. T. Johnson, “Warm autoantibody or drug-dependent antibody? That is the question!,” Immunohematology, vol. 23, no. 4, pp. 161–164, 2007. View at Google Scholar
  20. R. G. Bogle, S. B. Coade, S. Moncada, J. D. Pearson, and G. E. Mann, “Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells,” Biochemical and Biophysical Research Communications, vol. 180, no. 2, pp. 926–932, 1991. View at Publisher · View at Google Scholar
  21. R. S. Sprague, M. L. Ellsworth, A. H. Stephenson, M. E. Kleinhenz, and A. J. Lonigro, “Deformation-induced ATP release from red blood cells requires CFTR activity,” American Journal of Physiology, vol. 44, no. 5, part 2, pp. H1726–H1732, 1998. View at Google Scholar
  22. A. Jeffers, M. T. Gladwin, and D. B. Kim-Shapiro, “Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias,” Free Radical Biology and Medicine, vol. 41, no. 10, pp. 1557–1565, 2006. View at Publisher · View at Google Scholar · View at PubMed
  23. G. Champigny, J.-L. Imler, E. Puchelle et al., “A change in gating mode leading to increased intrinsic Cl- channel activity compensates for defective processing in a cystic fibrosis mutant corresponding to a mild form of the disease,” The EMBO Journal, vol. 14, no. 11, pp. 2417–2423, 1995. View at Google Scholar